Immune Pharmaceuticals

Last Updated 2021-08-03
  • Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing
  • Locations

    • New York NY
  • Total Funding (USD)

    12.0 million
  • Security

    Type: ORD
    CUSIP: 45254C200
    ISIN: US45254C2008
Filter date
Bookmark Created by Last updated
There were no results found.
Filter date
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.